SK14992000A3 - Spôsob inhibície mrpi - Google Patents
Spôsob inhibície mrpi Download PDFInfo
- Publication number
- SK14992000A3 SK14992000A3 SK1499-2000A SK14992000A SK14992000A3 SK 14992000 A3 SK14992000 A3 SK 14992000A3 SK 14992000 A SK14992000 A SK 14992000A SK 14992000 A3 SK14992000 A3 SK 14992000A3
- Authority
- SK
- Slovakia
- Prior art keywords
- phenyl
- alkyl
- alkoxy
- compound
- formula
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8108898P | 1998-04-08 | 1998-04-08 | |
| PCT/US1999/007615 WO1999051236A1 (en) | 1998-04-08 | 1999-04-07 | Methods for inhibiting mrp1 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK14992000A3 true SK14992000A3 (sk) | 2001-06-11 |
Family
ID=22162031
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1499-2000A SK14992000A3 (sk) | 1998-04-08 | 1999-04-07 | Spôsob inhibície mrpi |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6221876B1 (de) |
| EP (1) | EP1067932A4 (de) |
| JP (1) | JP2002510632A (de) |
| KR (1) | KR20010042481A (de) |
| CN (1) | CN1296410A (de) |
| AU (1) | AU3550299A (de) |
| BR (1) | BR9909446A (de) |
| CA (1) | CA2327452A1 (de) |
| EA (1) | EA200001035A1 (de) |
| HU (1) | HUP0102548A2 (de) |
| ID (1) | ID26804A (de) |
| IL (1) | IL138393A0 (de) |
| NO (1) | NO20005041D0 (de) |
| PL (1) | PL343320A1 (de) |
| SK (1) | SK14992000A3 (de) |
| TR (1) | TR200002804T2 (de) |
| WO (1) | WO1999051236A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6262098B1 (en) * | 1998-08-07 | 2001-07-17 | Chiron Corporation | Estrogen receptor modulators |
| US6743794B2 (en) | 1999-12-22 | 2004-06-01 | Eli Lilly And Company | Methods and compounds for inhibiting MRP1 |
| ATE282623T1 (de) * | 1999-12-22 | 2004-12-15 | Lilly Co Eli | Verfahren und verbindungen für die hemmung von mrp1 |
| EP1301518A1 (de) | 2000-06-14 | 2003-04-16 | Eli Lilly And Company | Tricyclische verbindungen mit mrp1-inhibierender wirkung |
| CA2442605A1 (en) | 2001-04-09 | 2002-10-17 | Mark Christopher Lohman | Compounds and methods for inhibiting mrp1 |
| CN1281210C (zh) * | 2003-11-29 | 2006-10-25 | 胡汛 | 五味子乙素在制备治疗肿瘤药物中的应用 |
| ATE396725T1 (de) * | 2004-05-14 | 2008-06-15 | Cleveland Clinic Foundation | Kleinmolekülige hemmer für mrp1 und andere multiarzneimitteltransporter |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5182290A (en) * | 1991-08-27 | 1993-01-26 | Neurogen Corporation | Certain oxazoloquinolinones; a new class of GABA brain receptor ligands |
-
1999
- 1999-04-07 BR BR9909446-0A patent/BR9909446A/pt not_active IP Right Cessation
- 1999-04-07 IL IL13839399A patent/IL138393A0/xx unknown
- 1999-04-07 JP JP2000542007A patent/JP2002510632A/ja not_active Withdrawn
- 1999-04-07 US US09/646,063 patent/US6221876B1/en not_active Expired - Fee Related
- 1999-04-07 ID IDW20002006A patent/ID26804A/id unknown
- 1999-04-07 TR TR2000/02804T patent/TR200002804T2/xx unknown
- 1999-04-07 SK SK1499-2000A patent/SK14992000A3/sk unknown
- 1999-04-07 CN CN99804797A patent/CN1296410A/zh active Pending
- 1999-04-07 EP EP99917359A patent/EP1067932A4/de not_active Withdrawn
- 1999-04-07 AU AU35502/99A patent/AU3550299A/en not_active Abandoned
- 1999-04-07 CA CA002327452A patent/CA2327452A1/en not_active Abandoned
- 1999-04-07 KR KR1020007011101A patent/KR20010042481A/ko not_active Application Discontinuation
- 1999-04-07 WO PCT/US1999/007615 patent/WO1999051236A1/en not_active Application Discontinuation
- 1999-04-07 PL PL99343320A patent/PL343320A1/xx not_active Application Discontinuation
- 1999-04-07 EA EA200001035A patent/EA200001035A1/ru unknown
- 1999-04-07 HU HU0102548A patent/HUP0102548A2/hu unknown
-
2000
- 2000-10-06 NO NO20005041A patent/NO20005041D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2327452A1 (en) | 1999-10-14 |
| US6221876B1 (en) | 2001-04-24 |
| NO20005041L (no) | 2000-10-06 |
| CN1296410A (zh) | 2001-05-23 |
| EP1067932A1 (de) | 2001-01-17 |
| KR20010042481A (ko) | 2001-05-25 |
| EA200001035A1 (ru) | 2001-04-23 |
| IL138393A0 (en) | 2001-10-31 |
| NO20005041D0 (no) | 2000-10-06 |
| TR200002804T2 (tr) | 2001-02-21 |
| PL343320A1 (en) | 2001-08-13 |
| EP1067932A4 (de) | 2001-11-14 |
| HUP0102548A2 (hu) | 2001-11-28 |
| AU3550299A (en) | 1999-10-25 |
| WO1999051236A1 (en) | 1999-10-14 |
| JP2002510632A (ja) | 2002-04-09 |
| BR9909446A (pt) | 2000-12-12 |
| ID26804A (id) | 2001-02-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2362876B1 (de) | Thienotriazolodiazepine derivaten aktiv auf apo a | |
| CZ2003539A3 (cs) | Vybrané kondenzované pyrrolokarbazoly | |
| SK822002A3 (en) | New compounds | |
| US6989387B2 (en) | Nitro and amino substituted topoisomerase agents | |
| SK14992000A3 (sk) | Spôsob inhibície mrpi | |
| US6369070B1 (en) | Methods for inhibiting mrp1 | |
| US6417193B1 (en) | Methods for inhibiting MRP1 | |
| US6673809B2 (en) | Tricyclic compounds as MRP1-inhibitors | |
| CZ20003689A3 (cs) | Způsob inhibice MRP1 | |
| CZ20003688A3 (cs) | Způsob inhibice MRP1 | |
| US20040010005A1 (en) | Stereoselective process for preparing cylcohexyl amine derivatives | |
| US20040116460A1 (en) | Compounds and pharmaceutical compositions for inhibiting mrp1 | |
| MXPA00009825A (en) | Methods for inhibiting mrp1 | |
| US7064131B2 (en) | Compounds and methods for inhibiting MRP1 | |
| MXPA00009814A (en) | Methods for inhibiting mrp1 | |
| CZ20003687A3 (cs) | Způsoby inhibice MRP1 | |
| JPH0834788A (ja) | ピロロベンゾカルバゾール誘導体及びその製造方法 | |
| MXPA00009655A (en) | Methods for inhibiting mrp1 | |
| CZ20001102A3 (cs) | Tabletová formulace pro trvalé uvolňování látky k léčbě Parkinsouovy nemoci |